ZNF569
Zinc finger protein 569
Also known as: FLJ32053, ZAP1, Zfp74, ZN569_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5MCW4
- Gene
- ZNF569
- Ensembl
- ENSG00000196437
- Chromosome
- 19
- Canonical length
- 686 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Golgi apparatus,Vesicles
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
686 residues, UniProt reviewed canonical sequence.
>Q5MCW4|ZNF569
1 MTESQGTVTF KDVAIDFTQE EWKRLDPAQR KLYRNVMLEN YNNLITVGYP FTKPDVIFKL
61 EQEEEPWVME EEVLRRHWQG EIWGVDEHQK NQDRLLRQVE VKFQKTLTEE KGNECQKKFA
121 NVFPLNSDFF PSRHNLYEYD LFGKCLEHNF DCHNNVKCLM RKEHCEYNEP VKSYGNSSSH
181 FVITPFKCNH CGKGFNQTLD LIRHLRIHTG EKPYECSNCR KAFSHKEKLI KHYKIHSREQ
241 SYKCNECGKA FIKMSNLIRH QRIHTGEKPY ACKECEKSFS QKSNLIDHEK IHTGEKPYEC
301 NECGKAFSQK QSLIAHQKVH TGEKPYACNE CGKAFPRIAS LALHMRSHTG EKPYKCDKCG
361 KAFSQFSMLI IHVRIHTGEK PYECNECGKA FSQSSALTVH MRSHTGEKPY ECKECRKAFS
421 HKKNFITHQK IHTREKPYEC NECGKAFIQM SNLVRHQRIH TGEKPYICKE CGKAFSQKSN
481 LIAHEKIHSG EKPYECNECG KAFSQKQNFI THQKVHTGEK PYDCNECGKA FSQIASLTLH
541 LRSHTGEKPY ECDKCGKAFS QCSLLNLHMR SHTGEKPYVC NECGKAFSQR TSLIVHMRGH
601 TGEKPYECNK CGKAFSQSSS LTIHIRGHTG EKPFDCSKCG KAFSQISSLT LHMRKHTGEK
661 PYHCIECGKA FSQKSHLVRH QRIHTHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF569 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- retina: 13 nTPM
- testis: 10 nTPM
- cerebellum: 5.2 nTPM
- ovary: 5.2 nTPM
- thyroid gland: 5.2 nTPM
- thymus: 4.8 nTPM
Single-cell type
- early spermatids: 202 nCPM
- late primary spermatocytes: 112 nCPM
- rod photoreceptor cells: 79 nCPM
- cone photoreceptor cells: 66 nCPM
- early primary spermatocytes: 62 nCPM
- late spermatids: 57 nCPM
Immune cell
- naive CD4 T-cell: 8 nTPM
- naive CD8 T-cell: 6.5 nTPM
- gdT-cell: 6.4 nTPM
- memory CD8 T-cell: 6.1 nTPM
- T-reg: 6.1 nTPM
- eosinophil: 5.9 nTPM
Brain region
- cerebellum: 25 nTPM
- white matter: 23 nTPM
- hypothalamus: 22 nTPM
- cerebral cortex: 21 nTPM
- midbrain: 20 nTPM
- choroid plexus: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.23
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF569 as an antibody target. Whether an autoantibody or antibody against ZNF569 could matter depends on whether native ZNF569 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF569 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF569 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...